MERUS LABS INTERNATIONAL INC T.MSL

James Hodgins

[retiredcf]

Is scheduled to be on Market Call Tonight on Thursday. It will be interesting to get his take on things given that he recently made MSL his top pick in a Globe & Mail article, not to mention, when he was last on BNN two months ago.  GLTA

MSL-T 2016-10-20 TOP PICK James Hodgins
 

They did not take on all the debt of some others.  It is in Europe.  When US drugs come off patent, it is a patent cliff.  In Europe it is different.  It tends to be about 30-40% because it is more highly regulated to begin with.  Their earnings are more stable.  He likes the management team who have been buying stock recently.  They changed from just buying legacy drugs to buying growth drugs.  He thinks this growth strategy will cause a re-rating of the stock.

 

Login to show your approval   Login to show your disapproval / Be the first to comment

Price:

$1.260

Subject:

MARKET NEUTRAL INVESTING: SMALL/MID-CAP

Bias:

NEUTRAL

Owned:

Yes

[puntacana]

This post has been removed in accordance with Community Policy

[kuatolives]

PHM, Concordia, Valeant, Merus, Nobilis..... these are the greatest hits of BNN "top picks" in the pharma space over the last couple of years. Do you really need any more evidence to stop listening to these bozos?

[Dojitrader15]

I honestly think this douche bag has a short position on each and every one of his top picks. There's just something about him, not sure why BNN even has him on anymore.

[Kensin1953]

Hard not to agree with you. Seems highly suspect.  What's the low $.50c  a few years back. I guess there has been no progress since then. No improvement in sales, no new agreements, no new aquisitions. TD just revised at $3.00 cdn  I guess they are also duped and are into recomending stocks to their universal clients that will ultimatley tank.  Whatever math they used ten

[Albanian]

I hope your not being serious on MJ stocks ? Why would you pay insane valuations for coMpanys that have nothing for sales. This is the problem with Merus and a bunch of healthcare stocks few years everyone was chasing em(including me) and were left holding at the end. That is happening with MJ and always a new hot sector. Just my opinion get in a stock that has good managment and low valuations

[Kensin1953]

No!  Just my futile attempt at being sarcastic.  I will check with my cat though. I'm all ears if you have some stocks that fit your criteria.  Sold ZEN, ROG, NXE too soon missed most of the upside. Hung on to XOP and MSL too long and not only nissed the upside but took a 25k bath on those and MSL seems to want to get worse. Not a good year for juniors for me.  Whining a